IsoRay Inc.

IsoRay Inc.
Stock Exchange NYSE
EPS
$0.1
Market Cap
$27.64 M
Shares Outstanding
67.34 M
Public Float
66.62 M

Profile

Address
350 Hills Street
Richland Washington 99354
United States
Employees -
Website http://www.isoray.com
Updated 07/08/2019
IsoRay, Inc. is a medical technology company. Though its subsidiary IsoRay Medical, Inc., it develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. Its product include Cesium-131 (Cs-131), a radioisotope for the treatment of prostate cancer, brain cancer, breast cancer, colorectal cancer, gynecological cancer, lung cancer, liver cancer, ocular melanoma, and pancreatic cancer.

Financials

View All

Lori A. Woods
Chief Executive Officer & Director
Michael W. McCormick
Chairman